↓ Skip to main content

Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin

Overview of attention for article published in BMC Infectious Diseases, February 2015
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
3 tweeters

Citations

dimensions_citation
49 Dimensions

Readers on

mendeley
72 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin
Published in
BMC Infectious Diseases, February 2015
DOI 10.1186/s12879-015-0781-7
Pubmed ID
Authors

Alexander Guschin, Pavel Ryzhikh, Tatiana Rumyantseva, Mikhail Gomberg, Magnus Unemo

Abstract

Azithromycin has been widely used for Mycoplasma genitalium treatment internationally. However, the eradication efficacy has substantially declined recent decade. In Russia, josamycin (another macrolide) is the recommended first-line treatment for M. genitalium infections, however, no data regarding treatment efficacy with josamycin and resistance in M. genitalium infections have been internationally published. We examined the M. genitalium prevalence in males attending an STI clinic in Moscow, Russia from December 2006 to January 2008, investigated treatment efficacy with josamycin in male urethritis, and monitored the M. genitalium DNA eradication dynamics and selection of macrolide resistance in M. genitalium during this treatment.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 72 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 72 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 11 15%
Student > Ph. D. Student 10 14%
Researcher 9 13%
Student > Master 9 13%
Student > Doctoral Student 5 7%
Other 15 21%
Unknown 13 18%
Readers by discipline Count As %
Medicine and Dentistry 13 18%
Agricultural and Biological Sciences 10 14%
Immunology and Microbiology 8 11%
Biochemistry, Genetics and Molecular Biology 5 7%
Nursing and Health Professions 4 6%
Other 17 24%
Unknown 15 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 May 2015.
All research outputs
#10,987,941
of 14,460,564 outputs
Outputs from BMC Infectious Diseases
#3,365
of 5,362 outputs
Outputs of similar age
#175,817
of 282,352 outputs
Outputs of similar age from BMC Infectious Diseases
#2
of 3 outputs
Altmetric has tracked 14,460,564 research outputs across all sources so far. This one is in the 20th percentile – i.e., 20% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,362 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one is in the 29th percentile – i.e., 29% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 282,352 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 32nd percentile – i.e., 32% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one.